Xellera Therapeutics Asia Limited

Xellera Therapeutics Asia Limited is a Hong Kong company, incorporated on Thursday - Jan. 02, 2014, as of today, the company has been operating for 10 years, 11 months, 2 days, Xellera Therapeutics Asia Limited located on 15 Science Park West Ave, Hong Kong. Its company status is Live. Its business name is 再心生物科技有限公司, company type is Private company limited by shares. browse more information on 996co.com.

Basic Info
  • Company Number: 2020088
  • Business Number: 62572972
  • Company Name: Xellera Therapeutics Asia Limited
  • Business Name: 再心生物科技有限公司
  • Company Status: Live
  • Incorporation Date:
  • Company Type: Private company limited by shares
  • Telephone: Display
  • Address: Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
  • Street: 15 Science Park West Ave
  • Area: New Territories
  • Directors: WING YAN, CAMIE CHAN,TANG WAI, RONALD ADOLPHUS LI
  • Number of Employees: 7
  • Name History: 01-Aug-2022
    Xellera Therapeutics Asia Limited02-Jan-2014
    NOVOHEART LIMITED
    再心生物科技有限公司
  • Register of Charges: Unavailable
  • Company Description: Novoheart Limited is located in Tai Po, Hong Kong and is part of the Medical & Diagnostic Laboratories Industry. Novoheart Limited has 7 total employees across all of its locations and generates 0.61 million in sales (USD).
  • News:

    NOTICE OF TRANSFER OF BUSINESS
    ———
    Pursuant to Sections 4 to 5 of the Transfer of Businesses (Protection of Creditors) Ordinance (Chapter 49 of the Laws of Hong Kong)
    ———
    NOTICE is hereby given that Xellera Therapeutics Limited, a company duly incorporated with limited liability under the laws of Hong Kong whose registered office is at  Unit 1801, 09–16, 18/F, Millennium City 5,  418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong (“Transferor”), which carries on business in biotechnology in Hong Kong under the name and image of “Xellera Therapeutics Limited”, has agreed to sell and transfer its business, including the goodwill thereof, and certain of its assets in Hong Kong (“Business”) to NOVOHEART LIMITED (再心生物科技有限公司), a company duly incorporated with limited liability under the laws of Hong Kong whose registered office is at Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong (“Transferee”).


    After the transfer of the Business, the Transferee intends to continue to carry on the Business at the same address.


    The effective date of transfer of the Business is 1 May 2022 (or such later date as the Transferor and the Transferee may agree) subject to all conditions required for completion being satisfied or waived.


    NOTICE is hereby given that upon the expiration of one (1) month after the date of the publication of this Notice pursuant to Section 5(3) of the Transfer of Businesses (Protection of Creditors) Ordinance, the liability of the Transferee (if any) for all the debts and obligations arising out of and in relation to the carrying on of the Business by the Transferor shall cease by virtue of the Transfer of Businesses (Protection of Creditors) Ordinance unless proceedings are instituted prior to the expiry of such one (1) month period.


    Dated 1 April 2022.


    Xellera Therapeutics Limited
    Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
    As Transferor


    NOVOHEART LIMITED  (再心生物科技有限公司)
    Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
    As Transferee

     

     

     

     

    NOTICE OF TRANSFER OF BUSINESS
    ———
    Pursuant to Sections 4 to 5 of the Transfer of Businesses (Protection of Creditors) Ordinance (Chapter 49 of the Laws of Hong Kong)
    ———
    NOTICE is hereby given that NOVOHEART LIMITED (再心生物科技有限公司), a company duly incorporated with limited liability under the laws of Hong Kong whose registered office is at Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong (“Transferor”), which carries on business in biotechnology under the name and image of “Novoheart”, has agreed to sell and transfer its business, including the goodwill thereof, and certain of its assets in  Hong Kong (“Business”) to NOVOHEART INTERNATIONAL LIMITED, a company duly incorporated with limited liability under the laws of Hong Kong whose registered office is at Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong (“Transferee”).


    After the transfer of the Business, the Transferee intends to continue to carry on the Business  at the same address.


    The effective date of transfer of the Business is 1 May 2022 (or such later date as the Transferor and the Transferee may agree) subject to all conditions required for completion being satisfied or waived.


    NOTICE is hereby given that upon the expiration of one (1) month after the date of the publication of this Notice pursuant to Section 5(3) of the Transfer of Businesses (Protection of Creditors) Ordinance, the liability of the Transferee (if any) for all the debts and obligations arising out of and in relation to the carrying on of the Business by the Transferor shall cease by virtue of the Transfer of Businesses (Protection of Creditors) Ordinance unless proceedings are instituted prior to the expiry of such one (1) month period.


    Dated 1 April 2022.


    NOVOHEART LIMITED  (再心生物科技有限公司)
    Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
    As Transferor


    NOVOHEART INTERNATIONAL LIMITED
    Unit 1801, 09–16, 18/F, Millennium City 5, 418 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
    As Transferee

  • Update Time: 2024-07-04
News Record
Matter Date
Change of Company Name 01 Aug, 2022
Company Established 02 Jan, 2014
FAQS
  • Q: When was the Hong Kong Xellera Therapeutics Asia Limited established?
  • A: Xellera Therapeutics Asia Limited was founded in 2014.
  • Q: What is Hong Kong company Xellera Therapeutics Asia Limited company type?
  • A: Xellera Therapeutics Asia Limited company type is Private company limited by shares.
  • Q: Who are the directors of Xellera Therapeutics Asia Limited?
  • A: The directors of Xellera Therapeutics Asia Limited is/are WING YAN, CAMIE CHAN,TANG WAI, RONALD ADOLPHUS LI.
  • Q: What's the contact number of Xellera Therapeutics Asia Limited? How to contact Xellera Therapeutics Asia Limited?
  • A: Hong Kong company Xellera Therapeutics Asia Limited contact number is +852-26183356! You can contact Xellera Therapeutics Asia Limited by phone.
Company Changes
Time Line of Xellera Therapeutics Asia Limited
  • Mon, 01-Aug-2022 Change of Company Name
  • Thu, 26-May-2022 Change of Company Secretary and Director
  • Wed, 26-Jan-2022 Change of Address of Registered Office
  • Thu, 02-Jan-2014 Established